Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation

被引:1
|
作者
Migliori, GB
Khomenko, AG
Punga, VV
Ambrosetti, M
Danilova, I
Ribka, LN
Grzemska, M
Sawert, H
Raviglione, MC
机构
[1] Fdn Salvatore Maugeri, Clin Lavoro Riabilitaz, Care & Res Inst, I-21049 Tradate, Italy
[2] Cent TB Res Inst, Moscow, Russia
[3] Ivanovo TB Dispensary, Ivanovo, Russia
[4] WHO, Global TB Programme, CH-1211 Geneva, Switzerland
[5] WHO, Country Off, Nonthaburi, Thailand
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Many of the current tuberculosis control programmes in the Russian Federation are based on costly strategies which are underfunded and use long, individualized treatment regimens. This article compares, using a cost-effectiveness analysis, the new WHO strategy implemented in the Ivanovo Oblast (case-finding among symptomatic patients (SCF) and shorter regimens) and the old strategy (active screening of the asymptomatic population (ACF) and longer regimens). The cost per case cured was calculated at different levels of cure rate (45-95%) using three scenarios to describe the new WHO strategy (use of WHO-recommended regimens and three options at increasing rates of admission) and a fourth scenario to describe the old strategy tall patients admitted for the whole treatment and longer regimens). The cost per case detected was determined by calculating the following: yield of the new and old strategy (number of examinations necessary to diagnose one case); cost of the diagnostic process; multiplying yield per cost according to the three scenarios describing the new WHO strategy and a fourth scenario describing the old strategy. In the Ivanovo Oblast the cost per case cured, at 85% cure rate level, ranged from US% 1197 (new strategy, scenario I without food) to US$ 6293 told strategy, scenario 4) the cost per case detected ranged from US$ 1581 (new strategy, scenario I) to US$ 4000 told strategy scenario 4). Significant savings can result from shifting towards the new WHO strategy. Decision-makers and health administrators should be responsible for re-investing the financial and human resources mobilized by the adoption of cost-effective strategies within the TB control programme.
引用
收藏
页码:475 / 483
页数:9
相关论文
共 50 条
  • [31] Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness
    Arinaminpathy, Nimalan
    Nandi, Arindam
    Vijayan, Shibu
    Jha, Nita
    Nair, Sreenivas A.
    Kumta, Sameer
    Dewan, Puneet
    Rade, Kiran
    Vadera, Bhavin
    Rao, Raghuram
    Sachdeva, Kuldeep S.
    BMJ GLOBAL HEALTH, 2021, 6 (10):
  • [32] Cost-effectiveness of renewable electricity policies
    Palmer, K
    Burtraw, D
    ENERGY ECONOMICS, 2005, 27 (06) : 873 - 894
  • [33] Cost-effectiveness Analysis of Vascular Access Referral Policies in CKD
    Shechter, Steven M.
    Chandler, Talon
    Skandari, M. Reza
    Zalunardo, Nadia
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (03) : 368 - 376
  • [34] PHARMACOECONOMIC STUDY OF BOTULINIUM TOXIN TYPE A IN TREATMENT OF POST-STROKE SPASTICITY IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS ANALYSIS
    Yagudina, R.
    Kulikov, A.
    Ugrekhelidze, D.
    VALUE IN HEALTH, 2014, 17 (07) : A395 - A395
  • [35] COST-EFFECTIVENESS ANALYSIS OF CEREBROLYSIN IN THE TREATMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE MODERATE AND SEVERE DEGREES OF SEVERITY IN THE RUSSIAN FEDERATION
    Kulikov, A.
    Abdrashitova, G.
    VALUE IN HEALTH, 2015, 18 (07) : A705 - A705
  • [36] COST-EFFECTIVENESS ANALYSIS OF BOSENTAN AND SILDENAFIL COMPARED WITH STANDARD THERAPY IN TREATMENT OF PRIMARY PULMONARY ARTERIAL HYPERTENSION IN RUSSIAN FEDERATION
    Omelyanovsky, V
    Avxentyeva, M.
    Krysanov, I
    Goryaynov, S.
    Ivakhnenko, O.
    Tsfasman, F. M.
    VALUE IN HEALTH, 2011, 14 (07) : A367 - A367
  • [37] Costs and outcomes of tuberculosis control in the Russian Federation: retrospective cohort analysis
    Atun, R. A.
    Samyshkin, Y.
    Drobniewski, F.
    Balabanova, Y.
    Fedorin, I. M.
    Lord, J.
    Coker, R. J.
    HEALTH POLICY AND PLANNING, 2006, 21 (05) : 353 - 364
  • [38] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
  • [39] A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective
    Burton, Robyn
    Henn, Clive
    Lavoie, Don
    O'Connor, Rosanna
    Perkins, Clare
    Sweeney, Kate
    Greaves, Felix
    Ferguson, Brian
    Beynon, Caryl
    Belloni, Annalisa
    Musto, Virginia
    Marsden, John
    Sheron, Nick
    LANCET, 2017, 389 (10078): : 1558 - 1580
  • [40] COST - EFFECTIVENESS ANALYSIS OF BUDESONID EASYHALER IN THE TREATMENT OF ASTHMA IN CHILDREN IN THE RUSSIAN FEDERATION
    Kulikov, A.
    Kilimanova, E.
    VALUE IN HEALTH, 2015, 18 (07) : A501 - A501